Showing results (1081-1090 of 1,170) with videos related to

Sort By:
Pageof 117
American Journal of Clinical Oncology|December 17, 2020
Nationwide Outcomes of Advanced Melanoma According to BRAFV600 StatusJesper van Breeschoten, Michel W J M Wouters, Liesbeth C de Wreede, et al.
British Journal of Cancer|January 26, 2021
First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysisJesper van Breeschoten, Michel W J M Wouters, Doranne L Hilarius, et al.
ESMO Open|December 2, 2021
Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugsM G Franken, B Leeneman, M J B Aarts, et al.
JCO Precision Oncology|September 21, 2022
BRAF and NRAS Mutation Status and Response to Checkpoint Inhibition in Advanced MelanomaOlivier J van Not, Willeke A M Blokx, Alfons J M van den Eertwegh, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2025
Induction therapy with BRAF/MEK inhibitors versus upfront ipilimumab/nivolumab in poor prognostic advanced melanomaM Bloem, A J M van den Eertwegh, J B A G Haanen, et al.
Scientific Reports|November 2, 2017
miR-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in irritable bowel syndromeCarolin Wohlfarth, Stefanie Schmitteckert, Janina D Härtle, et al.
International Journal of Cancer|February 27, 2023
Adjuvant treatment of in-transit melanoma: Narrowing the knowledge gap left by clinical trialsMelissa M de Meza, Willeke A M Blokx, Han J Bonenkamp, et al.
Annals of Internal Medicine|February 15, 2021
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease : A Cohort StudyMonique K van der Kooij, Karijn P M Suijkerbuijk, Maureen J B Aarts, et al.
Cancers|January 21, 2023
Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma: A Propensity-Matched Outcome AnalysisMelissa M De Meza, Willeke A M Blokx, Johannes J Bonenkamp, et al.
Cancers|July 31, 2020
Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and ResponseMonique K van der Kooij, Marjolein J A L Wetzels, Maureen J B Aarts, et al.
Pageof 117